name

Peter Diamandis

HQ Location: USA

RANK #552

Peter Diamandis is co-founder and board member of Lifeforce Digital. He is also co-founder and vice-chairman of Covaxx. He is chairman of the advisory board of Radicle Science. He is an advisor to Immunis. He is an advisor to Guardian Circle and Republic. He co-founded and serves as managing director and vice chairman of Space Adventures and Human Longevity. He is also a co-founder and general partner of Bold Capital Partners. He is a co-founder and board member of Herox. He is an observer on the board of directors of Virgin Hyperloop. He is a co-founder and advisor to Eleven. He is an advisor to OpenGate Capital. Co-founder and executive chairman of Singularity University. Co-founder and chairman of XPRIZE. Co-founder of Zero-G. Served as executive director at BlastOff! He is also an alumnus of Silicon Valley University, which advises the world's leaders on exponentially emerging technologies. In commercial space, he was co-founder and co-chairman of Planetary Resources, a company developing spacecraft to detect and search for fuel and valuable materials on asteroids. He was a member of the board of directors of Planetary Power. He has served as an advisor to Experfy and Global Ventures (Dubai). He is a member of the board of directors of Form Bio. Serves on the board of directors of Venom. Co-founder and Vice Chairman of Vaxxinity. He holds degrees in molecular genetics and aerospace engineering from MIT and a PhD from Harvard Medical School.

Numbers of Unicorns

2

224

Rank (Xs)

#552

Investments

32

Exits

14

Numbers of Unicorns

2

224

Rank (Xs)

#552

Investments

32

Exits

14

All Unicorns

Logo

Company name

ENTRY ROUND

VALUATION at entry ($M)

VALUATION 

Human Longevity

Human Longevity

Series A

$120M

83

$10000M

Magic Leap

Magic Leap

Series B

$1000.01M

2

$2000M

All $100M+

Company name

ENTRY ROUND

VALUATION at entry ($M)

VALUATION 

625

Booster

$8.9M

87

$775M

1662

Enlitic

$10M

13

$125M

2366

High Fidelity

Series A

$10M

18

$183.15M

5997

Virgin Hyperloop

Series A1

$33.61M

14

$472.23M

5993

Viome Life Sciences

Series A

$70M

5

$339M

5968

Vicarious

Series B

$220.82M

2

$400M

The information is provided for informational purposes.  The company does not bear any responsibility for the published data.